Scinovex
article Open AccessTop 1% cited

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome

Alimentary Pharmacology & Therapeutics · 2015 · Vol. 42(4) · pp. 418–427
Bruno P. ChumpitaziJulia CopeEmily B. HollisterC.-M. TsaiAnn R. McMeansRenato A. LunaJames VersalovicRobert J. Shulman

Abstract

In childhood IBS, a low FODMAP diet decreases abdominal pain frequency. Gut microbiome biomarkers may be associated with low FODMAP diet efficacy. ClinicalTrials.gov identifier: NCT01339117.

Gastrointestinal motility and disordersDiet and metabolism studiesGut microbiota and healthIrritable bowel syndromeMedicineGastroenterologyInternal medicineFaecalibacterium prausnitziiAbdominal painCrossover studyMicrobiomeGut floraPlacebo

MeSH terms

Gastrointestinal MicrobiomeAdolescentChildDisaccharidesDouble-Blind MethodFemaleFermentationHumansMaleMonosaccharidesOligosaccharidesPolymersRNA, Ribosomal, 16SBiomarkersAbdominal Pain

Funding

  • U.S. Department of Agriculture
  • Mead Johnson Nutrition
  • North American Society for Pediatric Gastroenterology, Hepatology and Nutrition
  • National Institutes of Health
  • NASPGHAN Foundation
  • National Research Council Canada
  • National Institute of Nursing Research
  • National Institute of Diabetes and Digestive and Kidney Diseases
Citations
420
FWCI
28.96
field-weighted impact
References
55
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome · Scinovex